• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
The Future of the Neurology Devices Market to 2016 – Market Forecasts, Competitive Landscape and Pipeline Analysis - Product Image

The Future of the Neurology Devices Market to 2016 – Market Forecasts, Competitive Landscape and Pipeline Analysis

  • ID: 1205543
  • February 2010
  • 74 Pages
  • GBI Research

FEATURED COMPANIES

  • Cordis Corporation
  • ev3
  • Medtronic
  • St. Jude Medical
  • MORE

“The Future of the Neurology Devices Market to 2016 - Market Forecasts, Competitive Landscape and Pipeline Analysis” provides key data, information and analysis on the global neurology devices market, a key segment within the medical device industry. This medical device report provides market landscape, competitive landscape and market trends information on five neurology devices market categories - CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology and Radiosurgery. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- Key geographies covered include the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Market size and company share data for five neurology READ MORE >

FEATURED COMPANIES

  • Cordis Corporation
  • ev3
  • Medtronic
  • St. Jude Medical
  • MORE

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 GBI Research Guidance

3 Neurology Devices: Market Characterization
3.1 Global Neurology Devices Market, Revenue ($ billion), 2002 – 2009
3.2 Global Neurology Devices Market, Revenue Forecast ($ billion), 2009 – 2016
3.3 Global Neurology Devices Market, Key Trends
3.3.1 Technological Advances to be a Mainstay in the Neurology Devices Market
3.3.2 Neurology Devices Market is Increasingly Attracting Interest from Cardiovascular Device Companies
3.3.3 Remote Patient Monitoring is a Distinct Possibility in near Future
3.4 Neurology Devices, Market Dynamics
3.4.1 Market Drivers
3.4.2 Market Restraints
3.5 Global Neurology Devices Market, Key Company Share (%), 2008

4 Global Neurology Devices Market: Category Analysis and Forecasts
4.1 Neurostimulation Devices
4.2 Neurostimulation Devices Market, Global, Revenue ($m), 2002 – 2009
4.3 Neurostimulation Devices Market, Global, Revenue Forecast ($m), 2009 – 2016
4.4 Neurostimulation Devices: Market Dynamics
4.4.1 Market Drivers
4.4.2 Market Restraints
4.5 Neurostimulation Devices Market, Global, Company Shares (%), 2008
4.6 Interventional Neurology
4.7 Interventional Neurology Market, Global, Revenue ($m), 2002 – 2009
4.8 Interventional Neurology Market, Global, Revenue Forecast ($m), 2009 – 2016
4.9 Interventional Neurology: Market Dynamics
4.9.1 Market Drivers
4.9.2 Market Restraints
4.10 Interventional Neurology Market, Global, Company Shares (%), 2008
4.11 CSF Management
4.12 CSF Management Market, Global, Revenue ($m), 2002 – 2009
4.13 Global CSF Management Market, Revenue Forecasts ($m), 2009 – 2016
4.14 CSF Management: Market Dynamics
4.14.1 Market Driver: Hydrocephalus Prevalence to Drive the Market in the Future
4.14.2 Market Restraint: Lack of Accurate Diagnosis is Slowing the Market Growth
4.15 Global CSF Management Market, Global, Company Shares (%), 2008
4.16 Neurosurgical Products
4.17 Neurosurgical Products Market, Global, Revenue ($m), 2002 – 2009
4.18 Neurosurgical Products Market, Global, Revenue Forecast ($m), 2009 – 2016
4.19 Neurosurgical Products: Market Dynamics
4.19.1 Market Drivers
4.19.2 Market Restraints: Technical Difficulties in Performing the Procedure and Advent of Ventricular Shunts is Slowing the Market Growth
4.20 Global Neurosurgical Products Market, Key Company Shares (%), 2008
4.21 Radiosurgery
4.22 Global Radiosurgery Market, Global, Revenue ($m), 2002 – 2009
4.23 Global Radiosurgery Market, Revenue Forecasts ($m), 2009 – 2016
4.24 Radiosurgery: Market Dynamics
4.24.1 Market Drivers
4.24.2 Market Restraint: High Cost of Radiosurgery Systems is Slowing the Purchasing Decision of the Hospitals
4.25 Global Radiosurgery Market, Key Company Shares (%), 2008

5 Global Neurology Devices Market: Country Analysis and Forecasts
5.1 Neurology Devices Market: Cross-Country Analysis
5.2 Revenue, By Country, 2002 – 2009
5.2.1 The US Neurology Devices Market, Revenues ($m), 2002 – 2009
5.2.2 Canada Neurology Devices Market, Revenues ($m), 2002 – 2009
5.2.3 The UK Neurology Devices Market, Revenues ($m), 2002 – 2009
5.2.4 Germany Neurology Devices Market, Revenues ($m), 2002 – 2009
5.2.5 France Neurology Devices Market, Revenues ($m), 2002 – 2009
5.2.6 Italy Neurology Devices Market, Revenues ($m), 2002 – 2009
5.2.7 Spain Neurology Devices Market, Revenues ($m), 2002 – 2009
5.2.8 Japan Neurology Devices Market, Revenues ($m), 2002 – 2009
5.2.9 China Neurology Devices Market, Revenues ($m), 2002 – 2009
5.2.10 India Neurology Devices Market, Revenues ($m), 2002 – 2009
5.2.11 Australia Neurology Devices Market, Revenues ($m), 2002 – 2009
5.2.12 Brazil Neurology Devices Market, Revenues ($m), 2002 – 2009
5.3 Revenue Forecasts, By Country, 2009 – 2016
5.3.1 The US Neurology Devices Market, Revenues ($m), 2009 – 2016
5.3.2 Canada Neurology Devices Market, Revenues ($m), 2009 – 2016
5.3.3 The UK Neurology Devices Market, Revenues ($m), 2009 – 2016
5.3.4 Germany Neurology Devices Market, Revenues ($m), 2009 – 2016
5.3.5 France Neurology Devices Market, Revenues ($m), 2009 – 2016
5.3.6 Italy Neurology Devices Market, Revenues ($m), 2009 – 2016
5.3.7 Spain Neurology Devices Market, Revenues ($m), 2009 – 2016
5.3.8 Japan Neurology Devices Market, Revenues ($m), 2009 – 2016
5.3.9 China Neurology Devices Market, Revenues ($m), 2009 – 2016
5.3.10 India Neurology Devices Market, Revenues ($m), 2009 – 2016
5.3.11 Australia Neurology Devices Market, Revenues ($m), 2009 – 2016
5.3.12 Brazil Neurology Devices Market, Revenues ($m), 2009 – 2016

6 Global Neurology Devices Market: Competitive Assessment
6.1 Medtronic
6.2 Boston Scientific Corporation
6.3 St. Jude Medical
6.4 Cordis Corporation
6.5 ev3

7 Global Neurology Devices Market: Product Pipeline Analysis
7.1 Neurostimulation Devices
7.1.1 Boston Scientific Corporation: Bion Microstimulator System
7.1.2 NeuroPro Technologies: Deep Brain Stimulation
7.1.3 Brainsway: Deep TMS H System
7.1.4 Cyberonics: Direct Deep Brain Stimulation
7.1.5 Intelect Medical: Enspire DBS Therapy system for stroke
7.1.6 Intelect Medical: Enspire Deep Stimulation therapy system
7.1.7 St. Jude Medical: Libra Deep Brain Stimulation System
7.1.8 St. Jude Medical: Libra Deep Brain Stimulation System-depression
7.1.9 St. Jude Medical: Libra Deep Brain Stimulation System-essential tremor
7.1.10 St. Jude Medical: LibraXP Deep Brain Stimulation System
7.1.11 The Magstim Company Limited: Magstim Rapid
7.1.12 Cleveland Medical Devices: ParkinTune
7.1.13 Northstar Neuroscience: Renova-DT Cortical Stimulation System
7.1.14 Duke University: Spinal Cord Stimulator
7.1.15 DynaMed Systems: Traxon
7.1.16 Cyberonics: 3T MRI Safe Lead
7.1.17 Cyberonics: Nerve Wrap
7.1.18 Cyberonics: Next Generation Programmer-VNS therapy
7.1.19 Cyberonics: Next Generation Wand-VNS therapy
7.1.20 Cyberonics: NXT HC-Pulse Generator
7.1.21 Cyberonics: NXT NP-Pulse Generator
7.1.22 Cyberonics: NXT SR-Pulse Generator
7.1.23 Boston Scientific Corporation: Precision Implantable neurostimulator
7.1.24 MICROTRANSPONDER: Wireless Vagus Nerve Stimulator
7.2 Interventional Neurology
7.2.1 Neurovasx: cPAX Aneurysm Treatment System
7.2.2 ev3: Pipeline Embolization Device
7.2.3 BioCure: GelCoil
7.2.4 Micrus Endovascular Corporation: Occlusion balloons
7.2.5 Micrus Endovascular Corporation: Cerecyte Microcoil
7.2.6 Micrus Endovascular Corporation: InterPaq Microcoil
7.2.7 Micrus Endovascular Corporation: MicruSphere Microcoil
7.2.8 Micrus Endovascular Corporation: UltiPaq Microcoil
7.2.9 Micrus Endovascular Corporation: Liquid embolic product
7.2.10 Valor Medical: Neucrylate
7.2.11 Surpass Medical Ltd: Brain Aneurysm Occluder
7.2.12 Micrus Endovascular Corporation: Flow diversion technology
7.2.13 W. L. Gore & Associates: GORE Embolic Filter
7.2.14 ev3: Solitaire FR Revascularization Device
7.3 CSF Management
7.3.1 NeuroDx Development LLC: ICP Check
7.3.2 Neuro Diagnostic Devices: Implantable ICP monitor
7.3.3 University of Cincinnati: Smart Sensor
7.3.4 University Hospital Zurich: SmartShunt
7.3.5 CSF Therapeutics: CSF Therapeutic device
7.3.6 NeuroSystems, LLC: Multimodality monitoring
7.3.7 Biosan Medical Ltd: Ventritek105
7.4 Neurosurgical Products
7.4.1 Xylos Corporation: Dura replacement product
7.4.2 JetGuide Ltd: JetGuide-Neuro
7.4.3 NICO Corporation: Myriad System
7.4.4 Renishaw plc: Neuroenhance
7.4.5 Renishaw plc: Neurolocate

8 Global Neurology Devices Market: Consolidation Landscape
8.1 Deals by Volume, 2006 – 2009
8.2 Key Deals in 2009
8.2.1 ev3 Completes Acquisition Of Chestnut Medical
8.2.2 St. Jude Medical Acquires Northstar Neuroscience

9 Appendix
9.1 Definitions
9.1.1 Neurology Devices
9.2 Acronyms
9.3 Research Methodology
9.3.1 Secondary Research
9.3.2 Primary Research
9.3.3 Models
9.3.4 Forecasts
9.3.5 Expert Panels
9.4 Contact Us
9.5 Disclaimer

List of Tables:

1.1 List of Tables

Table 1: Neurology Devices Market, Global, Revenue ($ billion), 2002 – 2009
Table 2: Neurology Devices Market, Global, Revenue ($ billion), 2009 – 2016
Table 3: Healthcare Expenditure as Percentage of GDP, Top 12 Countries, 2008
Table 4: Neurology Devices Market, Global, Company Share (%), 2008
Table 5: Neurostimulation Devices Market, Global, Revenue ($m), 2002 – 2009
Table 6: Neurostimulation Devices Market, Global, Overall Revenues ($m), 2009 – 2016
Table 7: 65 and older population (m), Global, Percentage of 65 and older population, 2008 – 2015
Table 8: Neurostimulation Devices Market, Global, Company Share (%), 2008
Table 9: Interventional Neurology Market, Global, Revenue ($m), 2002 – 2009
Table 10: Interventional Neurology Market, Global, Revenue ($m), 2009 – 2016
Table 11: Interventional Neurology Market, Global, Company Share (%), 2008
Table 12: CSF Management Market, Global, Revenue ($m), 2002 – 2009
Table 13: CSF Management Market, Global, Revenue ($m), 2009 – 2016
Table 14: CSF Management Market, Global, Company Shares (%), 2008
Table 15: Neurosurgical Products Market, Global, Revenue ($m), 2002 – 2009
Table 16: Neurosurgical Products Market, Global, Revenue ($m), 2009 – 2016
Table 17: Neurosurgical Products Market, Global, Company Share (%), 2008
Table 18: Radiosurgery Market, Global, Revenue ($m), 2002 – 2009
Table 19: Radiosurgery Market, Global, Overall Revenues ($m), 2009 – 2016
Table 20: Radiosurgery Market, Global, Company Share (%), 2008
Table 21: Neurology Devices Market, Cross-Country Analysis, Global, 2002 – 2016
Table 22: Neurology Devices Market, US, Overall Revenues ($ bn), 2002 – 2009
Table 23: Neurology Devices Market, Canada, Overall Revenues ($ bn), 2002 – 2009
Table 24: Neurology Devices Market, UK, Overall Revenues ($ bn), 2002 – 2009
Table 25: Neurology Devices Market, Germany, Overall Revenues ($ bn), 2002 – 2009
Table 26: Neurology Devices Market, France, Overall Revenues ($ bn), 2002 – 2009
Table 27: Neurology Devices Market, Italy, Overall Revenues ($ bn), 2002 – 2009
Table 28: Neurology Devices Market, Spain, Overall Revenues ($ bn), 2002 – 2009
Table 29: Neurology Devices Market, Japan, Overall Revenues ($ bn), 2002 – 2009
Table 30: Neurology Devices Market, China, Overall Revenues ($ bn), 2002 – 2009
Table 31: Neurology Devices Market, India, Overall Revenues ($ bn), 2002 – 2009
Table 32: Neurology Devices Market, Australia, Overall Revenues ($ bn), 2002 – 2009
Table 33: Neurology Devices Market, Brazil, Overall Revenues ($ bn), 2002 – 2009
Table 34: Neurology Devices Market, US, Overall Revenues ($m), 2009 – 2016
Table 35: Neurology Devices Market, Canada, Overall Revenues ($m), 2009 – 2016
Table 36: Neurology Devices Market, UK, Overall Revenues ($m), 2009 – 2016
Table 37: Neurology Devices Market, Germany, Overall Revenues ($m), 2009 – 2016
Table 38: Neurology Devices Market, France, Overall Revenues ($m), 2009 – 2016
Table 39: Neurology Devices Market, Italy, Overall Revenues ($m), 2009 – 2016
Table 40: Neurology Devices Market, Spain, Overall Revenues ($m), 2009 – 2016
Table 41: Neurology Devices Market, Japan, Overall Revenues ($m), 2009 – 2016
Table 42: Neurology Devices Market, China, Overall Revenues ($m), 2009 – 2016
Table 43: Neurology Devices Market, India, Overall Revenues ($m), 2009 – 2016
Table 44: Neurology Devices Market, Australia, Overall Revenues ($m), 2009 – 2016
Table 45: Neurology Devices Market, Brazil, Overall Revenues ($m), 2009 – 2016
Table 46: Company - Product Matrix, Neurology Devices Market, 2009
Table 47: Medtronic, Key Products, Neurology Devices, Global, 2009
Table 48: Boston Scientific Corporation, Key Products, Neurology Devices, Global, 2009
Table 49: St. Jude Medical, Key Products, Neurology Devices, Global, 2009
Table 50: Cordis Corporation, Key Products, Neurology Devices, Global, 2009
Table 51: ev3, Key Products, Neurology Devices, Global, 2009
Table 52: Neurostimulation Devices, Pipeline Products, 2009
Table 53: Interventional Neurology, Pipeline Products, 2009
Table 54: CSF Management, Pipeline Products, 2009
Table 55: Neurosurgical Products, Pipeline Products, 2009
Table 56: Neurology Devices Market, Mergers & Acquisitions, by Volume, Global, 2006 – 2009
Table 57: Neurology Devices Market, Mergers & Acquisitions, Global, 2006 – 2009

1.2 List of Figures:

Figure 1: Neurology Devices Market, Global, Revenue ($ billion), 2002 – 2009
Figure 2: Neurology Devices Market, Global, Revenue ($ billion), 2009 – 2016
Figure 3: Healthcare Expenditure as Percentage of GDP, Top 12 Countries, 2008
Figure 4: Neurology Devices Market, Global, Company Share (%), 2008
Figure 5: Neurostimulation Devices Market, Global, Revenue ($m), 2002 – 2009
Figure 6: Neurostimulation Devices Market, Global, Revenues ($m), 2009 – 2016
Figure 7: Neurostimulation Devices Market, Global, Company Share (%), 2008
Figure 8: Interventional Neurology Market, Global, Revenue ($m), 2002 – 2009
Figure 9: Interventional Neurology Market, Global, Revenue ($m), 2009 – 2016
Figure 10: Interventional Neurology Market, Global, Company Share (%), 2008
Figure 11: CSF Management Market, Global, Revenue ($m), 2002 – 2009
Figure 12: CSF Management Market, Global, Revenue ($m), 2009 – 2016
Figure 13: CSF Management Market, Global, Company Shares (%), 2008
Figure 14: Neurosurgical Products Market, Global, Revenue ($m), 2002 – 2009
Figure 15: Neurosurgical Products Market, Global, Revenue ($m), 2009 – 2016
Figure 16: Neurosurgical Products Market, Global, Company Share (%), 2008
Figure 17: Radiosurgery Market, Global, Revenue ($m), 2002 – 2009
Figure 18: Radiosurgery Market, Global, Overall Revenues ($m), 2009 – 2016
Figure 19: Radiosurgery Market, Global, Company Share (%), 2008
Figure 20: Neurology Devices Market, Cross-Country Analysis, Global, 2002 – 2016
Figure 21: Neurology Devices Market, US, Overall Revenues ($ bn), 2002 – 2009
Figure 22: Neurology Devices Market, Canada, Overall Revenues ($ bn), 2002 – 2009
Figure 23: Neurology Devices Market, UK, Overall Revenues ($ bn), 2002 – 2009
Figure 24: Neurology Devices Market, Germany, Overall Revenues ($ bn), 2002 – 2009
Figure 25: Neurology Devices Market, France, Overall Revenues ($ bn), 2002 – 2009
Figure 26: Neurology Devices Market, Italy, Overall Revenues ($ bn), 2002 – 2009
Figure 27: Neurology Devices Market, Spain, Overall Revenues ($ bn), 2002 – 2009
Figure 28: Neurology Devices Market, Japan, Overall Revenues ($ bn), 2002 – 2009
Figure 29: Neurology Devices Market, China, Overall Revenues ($ bn), 2002 – 2009
Figure 30: Neurology Devices Market, India, Overall Revenues ($ bn), 2002 – 2009
Figure 31: Neurology Devices Market, Australia, Overall Revenues ($ bn), 2002 – 2009
Figure 32: Neurology Devices Market, Brazil, Overall Revenues ($ bn), 2002 – 2009
Figure 33: Neurology Devices Market, US, Overall Revenues ($m), 2009 – 2016
Figure 34: Neurology Devices Market, Canada, Overall Revenues ($m), 2009 – 2016
Figure 35: Neurology Devices Market, UK, Overall Revenues ($m), 2009 – 2016
Figure 36: Neurology Devices Market, Germany, Overall Revenues ($m), 2009 – 2016
Figure 37: Neurology Devices Market, France, Overall Revenues ($m), 2009 – 2016
Figure 38: Neurology Devices Market, Italy, Overall Revenues ($m), 2009 – 2016
Figure 39: Neurology Devices Market, Spain, Overall Revenues ($m), 2009 – 2016
Figure 40: Neurology Devices Market, Japan, Overall Revenues ($m), 2009 – 2016
Figure 41: Neurology Devices Market, China, Overall Revenues ($m), 2009 – 2016
Figure 42: Neurology Devices Market, India, Overall Revenues ($m), 2009 – 2016
Figure 43: Neurology Devices Market, Australia, Overall Revenues ($m), 2009 – 2016
Figure 44: Neurology Devices Market, Brazil, Overall Revenues ($m), 2009 – 2016
Figure 45: Neurology Devices Market, Mergers & Acquisitions, by Volume, Global, 2006 – 2009
Figure 46: GBI Research Methodology

FEATURED COMPANIES

  • Cordis Corporation
  • ev3
  • Medtronic
  • St. Jude Medical
  • MORE

“The Future of the Neurology Devices Market to 2016 - Market Forecasts, Competitive Landscape and Pipeline Analysis” provides key data, information and analysis on the global neurology devices market. The report provides market landscape, competitive landscape and market trends information on five neurology devices market categories - CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology and Radiosurgery. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

The Global Neurology Devices Market to Exceed $5 billion by 2016

The global neurology devices market is forecast to exceed $5 billion by 2016 with a Compound Annual Growth Rate (CAGR) of 12.5% from 2009-2016.

Neurology Devices Market, Global, Overall Revenues ($ billion), 2009 – 2016

The market is expected to be driven by patient demographics, increasing physician adoption, patient demand and the availability of reimbursement for the procedures. Globally million people suffer from epilepsy at any given time and in the US, about three million individuals have some form of epilepsy. The huge patient population which is being affected with various neurological disorders presents huge growth opportunities for the market in the future. Neurological disorders such as epilepsy and chronic migraines do not respond well to drugs mean that neurological devices will move further up the continuum of care.

Neurostimulation Devices is the Fastest Growing Category in the Global Neurology Devices Market

Neurostimulation devices is the fastest growing category within the neurology devices market. It is forecast to grow at a CAGR of 15% for the next seven years to exceed $3.5 billion by 2016. Historically the market grew at a rate of 11.7% in the last seven years. The market is expected to be driven by it use in post cancer therapy pain, lower back pain, Parkinson’s disease, epilepsy, migraines and chronic pain. Clinical data supporting the use of neurology devices to treat various neurological disorders is expected to increase the physician adoption. Steady increase in the incidence rate of spinal disease and the increase in average life expectancy are expected to boost growth in the market.

- Medtronic
- Boston Scientific Corporation
- St. Jude Medical
- Cordis Corporation
- ev3

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos